These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38059331)

  • 1. HPV-negative head and neck cancers with adverse pathological features carry specific molecular changes that are associated with survival.
    Kim HAJ; Zeng PYF; Cecchini M; Shaikh MH; Laxague F; Deng X; Jarycki L; Ryan SEB; Dawson A; Liu MH; Palma DA; Patel K; Mundi N; Barrett JW; Mymryk JS; Boutros PC; Nichols AC
    Head Neck; 2024 Feb; 46(2):353-366. PubMed ID: 38059331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The addition of chemotherapy to adjuvant radiation is associated with inferior survival outcomes in intermediate-risk HPV-negative HNSCC.
    Tasoulas J; Lenze NR; Farquhar D; P Schrank T; Shen C; Shazib MA; Singer B; Patel S; Grilley Olson JE; Hayes DN; Gulley ML; Chera BS; Hackman T; Olshan AF; Weiss J; Sheth S
    Cancer Med; 2021 May; 10(10):3231-3239. PubMed ID: 33934525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-risk pathological features at the time of salvage surgery predict poor survival after definitive therapy in patients with head and neck squamous cell carcinoma.
    Haque S; Karivedu V; Riaz MK; Choi D; Roof L; Hassan SZ; Zhu Z; Jandarov R; Takiar V; Tang A; Wise-Draper T
    Oral Oncol; 2019 Jan; 88():9-15. PubMed ID: 30616803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Tumor Site With the Prognosis and Immunogenomic Landscape of Human Papillomavirus-Related Head and Neck and Cervical Cancers.
    Zhu G; Amin N; Herberg ME; Maroun CA; Wang H; Guller M; Gourin CG; Rooper LM; Vosler PS; Tan M; D'Souza G; Koch WM; Eisele DW; Seiwert TY; Fakhry C; Pardoll DM; Mandal R
    JAMA Otolaryngol Head Neck Surg; 2022 Jan; 148(1):70-79. PubMed ID: 34792560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular prognosticators in clinically and pathologically distinct cohorts of head and neck squamous cell carcinoma-A meta-analysis approach.
    Reddy RB; Khora SS; Suresh A
    PLoS One; 2019; 14(7):e0218989. PubMed ID: 31310629
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Cao CH; Liu R; Lin XR; Luo JQ; Cao LJ; Zhang QJ; Lin SR; Geng L; Sun ZY; Ye SK; Yu ZY; Shi Y; Xia X
    Int J Biol Sci; 2021; 17(7):1744-1756. PubMed ID: 33994859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic changes of the EMT spectrum between circulating tumor cells and the tumor microenvironment in human papillomavirus-positive head and neck squamous cell carcinoma.
    Ida S; Takahashi H; Tada H; Mito I; Matsuyama T; Chikamatsu K
    Oral Oncol; 2023 Feb; 137():106296. PubMed ID: 36571985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA-Methylome-Based Tumor Hypoxia Classifier Identifies HPV-Negative Head and Neck Cancer Patients at Risk for Locoregional Recurrence after Primary Radiochemotherapy.
    Tawk B; Rein K; Schwager C; Knoll M; Wirkner U; Hörner-Rieber J; Liermann J; Kurth I; Balermpas P; Rödel C; Linge A; Löck S; Lohaus F; Tinhofer I; Krause M; Stuschke M; Grosu AL; Zips D; Combs SE; Belka C; Stenzinger A; Herold-Mende C; Baumann M; Schirmacher P; Debus J; Abdollahi A
    Clin Cancer Res; 2023 Aug; 29(16):3051-3064. PubMed ID: 37058257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High USP4 mRNA is associated with an HPV-positive status in head and neck squamous cell carcinoma patients.
    Scheiflinger A; Al-Gboore S; Jank BJ; Brkic F; Kadletz-Wanke L; Kenner L; Heiduschka G; Schnoell J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10675-10683. PubMed ID: 37308746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A gene expression profile associated with perineural invasion identifies a subset of HNSCC at risk of post-surgical recurrence.
    Saidak Z; Clatot F; Chatelain D; Galmiche A
    Oral Oncol; 2018 Nov; 86():53-60. PubMed ID: 30409320
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Sailer V; Holmes EE; Gevensleben H; Goltz D; Dröge F; Franzen A; Dietrich J; Kristiansen G; Bootz F; Schröck A; Dietrich D
    Clin Epigenetics; 2017; 9():12. PubMed ID: 28174607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A combination of intra-tumor genetic heterogeneity, estrogen receptor alpha and human papillomavirus status predicts outcomes in head and neck squamous cell carcinoma following chemoradiotherapy.
    Patel KB; Mroz EA; Faquin WC; Rocco JW
    Oral Oncol; 2021 Sep; 120():105421. PubMed ID: 34198234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
    Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J
    Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.
    Yang L; Kumar B; Shen C; Zhao S; Blakaj D; Li T; Romito M; Teknos TN; Williams TM
    Mol Cancer Ther; 2019 Jun; 18(6):1025-1035. PubMed ID: 31015310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Brain metastasis from squamous cell carcinoma of the head and neck: a review of the literature in the genomic era.
    Barrett TF; Gill CM; Miles BA; Iloreta AMC; Bakst RL; Fowkes M; Brastianos PK; Bederson JB; Shrivastava RK
    Neurosurg Focus; 2018 Jun; 44(6):E11. PubMed ID: 29852772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Cell Transcriptome Analysis Reveals Different Immune Signatures in HPV- and HPV + Driven Human Head and Neck Squamous Cell Carcinoma.
    Li S; Wang Y; Sun R; Franceschi D; Pan H; Wei C; Ogbuehi AC; Lethaus B; Savkovic V; Gaus S; Zimmerer R; Ziebolz D; Schmalz G; Jiang X
    J Immunol Res; 2022; 2022():2079389. PubMed ID: 36157879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Establishment of a Machine Learning Model for the Risk Assessment of Perineural Invasion in Head and Neck Squamous Cell Carcinoma.
    Weusthof C; Burkart S; Semmelmayer K; Stögbauer F; Feng B; Khorani K; Bode S; Plinkert P; Plath K; Hess J
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.